MRI changes in time after cranial irradiation, and their relation with pituitary function in survivors of childhood medulloblastoma

Autor: van Ommen, CCN, van Iersel, L, Lequin, MH, Clement, SC, Janssens, GOR, Boot, Annemieke M, Caron, Huib N., Claahsen-van der Grinten, Hedi L, Granzen, Bernd, Han, KS, Michiels, Erna M., Trotsenburg, A.S., Vandertop, W. Peter, van Vuurden, Dannis G, Schouten-van Meeteren, Annetteke Y N, van Santen, HM, Kremer, L.C.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10691::da8604f9fbfba5adc52242dd40005a05
https://dspace.library.uu.nl/handle/1874/374610

Prevalence, risk factors, and optimal way to determine overweight, obesity, and morbid obesity in the first Dutch cohort of 2338 long-term survivors of childhood cancer: a DCCSS-LATER study.

Autor: Pluimakers VG; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., van Atteveld JE; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., de Winter DTC; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Bolier M; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Fiocco M; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Medical Statistics, Department of Biomedical Data Science, Leiden UMC, Leiden 2333 ZA, The Netherlands.; Mathematical Institute Leiden University, Leiden 2333 ZA, The Netherlands., Nievelstein RJAJ; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Radiology & Nuclear Medicine, UMC Utrecht, Utrecht 3584 CX, The Netherlands., Janssens GOR; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Radiation Oncology, UMC Utrecht, Utrecht 3584 CX, The Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., van der Heiden-van der Loo M; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., de Vries ACH; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Sophia Children's Hospital/Erasmus MC, Rotterdam 3015 CN, The Netherlands., Louwerens M; Department of Internal Medicine, Leiden UMC, Leiden 2333 ZA, The Netherlands., van der Pal HJ; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Pluijm SMF; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Ronckers CM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Health Services Research, Carl von Ossietzky University of Oldenburg, Oldenburg 26129, Germany., Versluijs AB; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Pediatric Oncology and Hematology, Wilhelmina Children's Hospital/UMC Utrecht, Utrecht 3584 EA, The Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Pediatric Oncology, Emma Children's Hospital/Amsterdam UMC, Amsterdam 1105 AZ, The Netherlands., Loonen JJ; Department of Hematology, Radboud UMC, Nijmegen 6525 GA, The Netherlands., van Dulmen-den Broeder E; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, University of Groningen, UMC Groningen, Groningen 9713 GZ, The Netherlands., van Santen HM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital/UMC Utrecht, Utrecht 3584 EA, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Neggers SJCMM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Medicine, Section Endocrinology, Erasmus MC, Rotterdam 3015 GD, The Netherlands.

Publikováno v: European journal of endocrinology [Eur J Endocrinol] 2023 Nov 08; Vol. 189 (5), pp. 495-507.

Characteristics and outcome of children with renal tumors in the Netherlands: The first five-year's experience of national centralization.

Autor: Roy P; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Peer SE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Witte MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Tytgat GAM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Karim-Kos HE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands., van Grotel M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van de Ven CP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Mavinkurve-Groothuis AMC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Merks JHM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kuiper RP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Clinical Genetics, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Hol JA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Janssens GOR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Radiation Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., de Krijger RR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pathology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Jongmans MCJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Clinical Genetics, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Drost J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van der Steeg AFW; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Littooij AS; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital (UMCU), Utrecht, The Netherlands., Wijnen MHWA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Tinteren H; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Publikováno v: PloS one [PLoS One] 2022 Jan 13; Vol. 17 (1), pp. e0261729. Date of Electronic Publication: 2022 Jan 13 (Print Publication: 2022).

Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population-based study during 1990-2015.

Autor: Reedijk AMJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Zijtregtop EAM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group, Utrecht, the Netherlands., Coebergh JWW; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands., Meyer-Wentrup FAG; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group, Utrecht, the Netherlands., Hebeda KM; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Zwaan CM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group, Utrecht, the Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus University Medical Center, Sophia Children's Hospital, Rotterdam, the Netherlands., Janssens GOR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Dinmohamed AG; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Zijlstra JM; Department of Hematology location VU Medical Center, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, the Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Oncology, Amsterdam UMC, Amsterdam, the Netherlands., Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Beishuizen A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group, Utrecht, the Netherlands., Karim-Kos HE; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.

Publikováno v: British journal of haematology [Br J Haematol] 2020 Jun; Vol. 189 (6), pp. 1093-1106. Date of Electronic Publication: 2020 Feb 06.

Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

Autor: El-Khouly FE; Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. f.el-khouly@amsterdamumc.nl.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. f.el-khouly@amsterdamumc.nl.; Department of Pediatric Oncology/Hematology, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. f.el-khouly@amsterdamumc.nl., Veldhuijzen van Zanten SEM; Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Santa-Maria Lopez V; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, St Joan de Déu Children´s Hospital, Barcelona, Spain., Hendrikse NH; Department of Clinical Pharmacology & Pharmacy, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Kaspers GJL; Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Loizos G; Pediatric Oncology-Hematology Clinic, Archbishop Makarios III Hospital, Nicosia, Cyprus., Sumerauer D; Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, University Hospital Motol, Charles University, Prague, Czech Republic., Nysom K; Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark., Pruunsild K; Department of Hematology and Oncology, Tallinn Children's Hospital, Tallinn, Estonia., Pentikainen V; Division of Hematology-Oncology and Stem Cell Transplantation, Children's Hospital, Helsinki University Hospital, Helsinki, Finland., Thorarinsdottir HK; Pediatric Hematology-Oncology, The Children's Hospital, Reykjavík, Iceland., Rutkauskiene G; Department of Pediatric Oncology and Hematology, Hospital of Lithuanian University of Health Sciences Kaunas Clinic, Kaunas, Lithuania., Calvagna V; Mater Dei Hospital, Valletta, Malta., Drogosiewicz M; Children's Memorial Health Institute, Warsaw, Poland., Dragomir M; Department of Pediatric Oncology, Oncology Institute Professor Doctor Alexandru Trestioreanu, Bucharest, Romania., Deak L; Department of Pediatric Oncology/Hematology, Children University Hospital, Kosice, Slovakia., Kitanovski L; Division of Hemato-Oncology, Department of Pediatrics, University Medical Center Ljubljana, Ljubljana, Slovenia., von Bueren AO; Pediatric Oncology and Hematology, Department of Pediatrics, University Hospital of Geneva, Geneva, Switzerland., Kebudi R; Pediatric Hematology-Oncology, Cerrahpasa Medical Faculty & Oncology Institute, Istanbul University, Istanbul, Turkey., Slavc I; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria., Jacobs S; Universitair Ziekenhuis Leuven, Leuven, Belgium., Jadrijevic-Cvrlje F; Department of Oncology and Hematology, Children's Hospital Zagreb, Zagreb, Croatia., Entz-Werle N; CHRU Hautepierre Strasbourg, Service de Pédiatrie Onco-Hématologie, Strasbourg, France., Grill J; Département de Cancérologie de l'enfant et de l'adoloscent, CLCC Institut Gustave Roussy, Villejuif, France., Kattamis A; First Department of Pediatrics, 'Aghia Sofia' Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece., Hauser P; Second Department of Pediatrics, Semmelweis University, Budapest, Hungary., Pears J; Department of Pediatric Oncology, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland., Biassoni V; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Massimino M; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lopez Aguilar E; Hospital de Pediatría, Centro Médico National Siglo XXI, Instituto Mexicano del Seguro Social, Jefatura de Servicio de Oncologia, Distrito Federal, Mexico., Torsvik IK; Division of Oncology/Hematology, Department of Pediatrics, Haukeland University Hospital, Mons, Norway., Joao Gil-da-Costa M; Pediatric Hematology and Oncology Division, University Hospital S. João Alameda Hernani Monteiro, Porto, Portugal., Kumirova E; Department of Neurooncology, Federal Research and Clinical Centre of Pediatric Hematology, Oncology and Immunology (FRC-PHOI), Moscow, Russia., Cruz-Martinez O; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, St Joan de Déu Children´s Hospital, Barcelona, Spain., Holm S; Department of Pediatric Hematology and Oncology, Department of Woman and Child Health, Karolinska University Hospital, Stockholm, Sweden., Bailey S; Great North Children's Hospital, Victoria Wing, Royal Victoria Infirmary, Newcastle upon Tyne, UK., Hayden T; The DIPG Collaborative, Cincinnati, USA., Thomale UW; Pediatric Neurosurgery, Charité University Medical Center Berlin, Berlin, Germany., Janssens GOR; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Kramm CM; Division of Pediatric Hematology and Oncology, University Medical Center Geottingen, Göttingen, Germany., van Vuurden DG; Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Publikováno v: Journal of neuro-oncology [J Neurooncol] 2019 Oct; Vol. 145 (1), pp. 177-184. Date of Electronic Publication: 2019 Sep 14.